Skye Bioscience Inc (OTCMKTS:SKYE) Stock On Radar Following Recent news

October 3, 2022

Pharmaceutical company developing synthetic cannabinoid derivatives for treating glaucoma and other diseases, Skye Bioscience Inc (OTCMKTS:SKYE) on October 1, 2022, reported that its stockholders voted in favor of all proposals. These were presented at a special meeting and included a proposal to approve the proposed acquisition of Emerald Health Therapeutics, Inc. Trading Data On Friday, SKYE stock moved down 3.35% to $0.0260 with more than 257.90K shares, compared to its…

Read More >>